{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:14:22Z","timestamp":1788394462650,"version":"build-2803163510"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017527","name":"Jiangsu Cancer Hospital","doi-asserted-by":"publisher","award":["RCQY202406"],"award-info":[{"award-number":["RCQY202406"]}],"id":[{"id":"10.13039\/501100017527","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nanjing Municipal Science and Technology Bureau through its International\/Hong Kong, Macao and Taiwan Joint Research and Development Program","award":["202512032"],"award-info":[{"award-number":["202512032"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Penile squamous cell carcinoma (PSCC) is a rare malignancy with limited genomic data in Asian populations. Lymph node metastasis heavily dictates prognosis, yet molecular determinants of progression remain poorly understood. We aimed to characterize the genomic landscape and explore candidate prognostic genomic features using paired primary and metastatic PSCC tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>Targeted next-generation sequencing (437 cancer-related genes) was performed on primary tumors and matched lymph node metastases from 20 Chinese patients. Somatic alterations, intralesional heterogeneity, and tumor mutation burden (TMB) were analyzed and correlated with disease-free survival (DFS) and overall survival (OS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The most frequent primary tumor mutations included TP53 (45%) and TERT (40%). Notably, CCND1\/FGF19 co-amplification (20% of cases) was associated with inferior DFS (P\u2009=\u2009.027) and showed a trend toward shorter OS (P\u2009=\u2009.050). Conversely, T-cell receptor (TCR) pathway alterations correlated with markedly improved survival. Comparing paired lesions revealed 59.8% shared alterations. Elevated TMB in metastases relative to matched primary tumors was significantly associated with poorer DFS (P\u2009=\u2009.008), while higher intralesional heterogeneity showed a trend toward worse OS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Paired profiling revealed broadly conserved genomic features together with lesion-specific divergence in PSCC. Recurrent CCND1\/FGF19-containing 11q13 amplification, TCR pathway alterations, and elevated metastatic TMB warrant evaluation as potential prognostic features in larger, independently validated cohorts with integrated HPV and immune profiling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/oncolo\/oyag319","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:32:12Z","timestamp":1787837532000},"source":"Crossref","is-referenced-by-count":0,"title":["Paired genomic profiling of primary tumor and lymph-node metastases identifies candidate prognostic features in penile squamous cell carcinoma"],"prefix":"10.1093","volume":"31","author":[{"given":"Kexin","family":"Lou","sequence":"first","affiliation":[{"name":"Department of Pathology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University , Nanjing, 210009,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghui","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University , Nanjing, 210009,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University , Nanjing, 210009,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University , Nanjing, 210009,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fufeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Nanjing Geneseeq Technology Inc. , Nanjing, 210000,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-1949","authenticated-orcid":false,"given":"Di","family":"Wang","sequence":"additional","affiliation":[{"name":"Nanjing Geneseeq Technology Inc. , Nanjing, 210000,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4159-0099","authenticated-orcid":false,"given":"Qifan","family":"Jing","sequence":"additional","affiliation":[{"name":"Nanjing Geneseeq Technology Inc. , Nanjing, 210000,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9523-1930","authenticated-orcid":false,"given":"Jiani C","family":"Yin","sequence":"additional","affiliation":[{"name":"Nanjing Geneseeq Technology Inc. , Nanjing, 210000,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urologic Surgery, The Second People's Hospital of Kunshan , Kunshan, 215300,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1221-3954","authenticated-orcid":false,"given":"Zicheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University , Nanjing, 210009,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2026090219265034300_oyag319-B1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-021-00246-5","article-title":"Penile cancer","volume":"7","author":"Thomas","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026090219265034300_oyag319-B2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jjco\/hyw034","article-title":"Urologic cancer in China","volume":"46","author":"Pang","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"2026090219265034300_oyag319-B3","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/ijc.32373","article-title":"Mutational landscape of penile squamous cell carcinoma in a Chinese population","volume":"145","author":"Wang","year":"2019","journal-title":"Int J Cancer"},{"key":"2026090219265034300_oyag319-B4","doi-asserted-by":"crossref","first-page":"102736","DOI":"10.1016\/j.fjurol.2024.102736","article-title":"French AFU cancer committee guidelines\u2013update 2024-2026: penile cancer","volume":"34","author":"Neuville","year":"2024","journal-title":"Fr J Urol"},{"key":"2026090219265034300_oyag319-B5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jcp.2008.063149","article-title":"Human papillomavirus prevalence and type distribution in penile carcinoma","volume":"62","author":"Miralles-Guri","year":"2009","journal-title":"J Clin Pathol"},{"key":"2026090219265034300_oyag319-B6","doi-asserted-by":"crossref","first-page":"593751","DOI":"10.1155\/2011\/593751","article-title":"Current and future strategies in the diagnosis and management of penile cancer","volume":"2011","author":"Lawindy","year":"2011","journal-title":"Adv Urol"},{"key":"2026090219265034300_oyag319-B7","doi-asserted-by":"crossref","first-page":"102323","DOI":"10.1016\/j.clgc.2025.102323","article-title":"Impact of TP53 alterations on clinical outcomes in penile squamous cell carcinoma","volume":"23","author":"Li","year":"2025","journal-title":"Clin Genitourin Cancer"},{"key":"2026090219265034300_oyag319-B8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.juro.2010.10.058","article-title":"Identification of high risk pathological node positive penile carcinoma: value of preoperative computerized tomography imaging","volume":"185","author":"Graafland","year":"2011","journal-title":"J Urol"},{"key":"2026090219265034300_oyag319-B9","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.juro.2007.12.040","article-title":"PIK3CA, HRAS and KRAS gene mutations in human penile cancer","volume":"179","author":"Andersson","year":"2008","journal-title":"J Urol"},{"key":"2026090219265034300_oyag319-B10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-9378-8-2","article-title":"Somatic mutations of STK11 gene in human papillomavirus positive and negative penile cancer","volume":"8","author":"Annunziata","year":"2013","journal-title":"Infect Agent Cancer"},{"key":"2026090219265034300_oyag319-B11","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-15-3134","article-title":"CSN1 somatic mutations in penile squamous cell carcinoma","volume":"76","author":"Feber","year":"2016","journal-title":"Cancer Res"},{"key":"2026090219265034300_oyag319-B12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/gcc.22274","article-title":"Identification of somatic gene mutations in penile squamous cell carcinoma","volume":"54","author":"Ferr\u00e1ndiz-Pulido","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"2026090219265034300_oyag319-B13","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","article-title":"Genomic profiling of penile squamous cell carcinoma reveals new opportunities for targeted therapy","volume":"75","author":"McDaniel","year":"2015","journal-title":"Cancer Res"},{"key":"2026090219265034300_oyag319-B14","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1158\/1078-0432.CCR-17-2310","article-title":"Investigating novel resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer patients","volume":"24","author":"Yang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026090219265034300_oyag319-B15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41598-017-00520-1","article-title":"Circulating tumor DNA mutation profiling by targeted next generation sequencing provides guidance for personalized treatments in multiple cancer types","volume":"7","author":"Shu","year":"2017","journal-title":"Sci Rep"},{"key":"2026090219265034300_oyag319-B16","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1158\/1078-0432.CCR-19-0585","article-title":"Comprehensive genomic profiling identifies novel genetic predictors of response to anti-PD-(L)1 therapies in non-small cell lung cancer","volume":"25","author":"Fang","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026090219265034300_oyag319-B17","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002223","article-title":"Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial","volume":"9","author":"Huang","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026090219265034300_oyag319-B18","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"2026090219265034300_oyag319-B19","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2026090219265034300_oyag319-B20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"key":"2026090219265034300_oyag319-B21","doi-asserted-by":"crossref","first-page":"D840","DOI":"10.1093\/nar\/gkw971","article-title":"The ExAC browser: displaying reference data information from over 60 000 exomes","volume":"45","author":"Karczewski","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2026090219265034300_oyag319-B22","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","article-title":"Tumor mutational burden as a predictive biomarker in solid tumors","volume":"10","author":"Sha","year":"2020","journal-title":"Cancer Discov"},{"key":"2026090219265034300_oyag319-B23","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.7150\/thno.34070","article-title":"Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer","volume":"9","author":"Tong","year":"2019","journal-title":"Theranostics"},{"key":"2026090219265034300_oyag319-B24","doi-asserted-by":"crossref","first-page":"608742","DOI":"10.3389\/fgene.2021.608742","article-title":"Genomic profiling reveals the molecular landscape of gastrointestinal tract cancers in Chinese patients","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Genet"},{"key":"2026090219265034300_oyag319-B25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"2026090219265034300_oyag319-B26","doi-asserted-by":"crossref","first-page":"180015","DOI":"10.1038\/sdata.2018.15","article-title":"ImmPort, toward repurposing of open access immunological assay data for translational and clinical research","volume":"5","author":"Bhattacharya","year":"2018","journal-title":"Sci Data"},{"key":"2026090219265034300_oyag319-B27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.18632\/oncotarget.28584","article-title":"Cyclin D1 expression in penile cancer","volume":"15","author":"Duarte","year":"2024","journal-title":"Oncotarget"},{"key":"2026090219265034300_oyag319-B28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00428-020-02831-7","article-title":"Prevalence of human papillomavirus and implication on survival in chinese penile cancer","volume":"477","author":"Chu","year":"2020","journal-title":"Virchows Arch"},{"key":"2026090219265034300_oyag319-B29","doi-asserted-by":"crossref","first-page":"846744","DOI":"10.3389\/fonc.2022.846744","article-title":"FGF19 is coamplified with CCND1 to promote proliferation in lung squamous cell carcinoma and their combined inhibition shows improved efficacy","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"2026090219265034300_oyag319-B30","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1158\/1078-0432.CCR-07-1247","article-title":"Amplicon mapping and expression profiling identify the fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal\/pharyngeal cancer","volume":"13","author":"Gibcus","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2026090219265034300_oyag319-B31","doi-asserted-by":"crossref","first-page":"e93210","DOI":"10.1371\/journal.pone.0093210","article-title":"Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in Asian populations: insights from a meta-analysis","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"2026090219265034300_oyag319-B32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1470-2045(07)70137-7","article-title":"Molecular and genetic pathways in penile cancer","volume":"8","author":"Kayes","year":"2007","journal-title":"Lancet Oncol"},{"key":"2026090219265034300_oyag319-B33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.eururo.2024.03.038","article-title":"Single-cell atlas of penile cancer reveals TP53 mutations as a driver of an aggressive phenotype, irrespective of human papillomavirus status, and provides clues for treatment personalization","volume":"86","author":"Elst","year":"2024","journal-title":"Eur Urol"},{"key":"2026090219265034300_oyag319-B34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cell.2020.05.039","article-title":"Multimodal analysis of composition and spatial architecture in human squamous cell carcinoma","volume":"182","author":"Ji","year":"2020","journal-title":"Cell"},{"key":"2026090219265034300_oyag319-B35","doi-asserted-by":"crossref","first-page":"658611","DOI":"10.3389\/fimmu.2021.658611","article-title":"Naturally occurring genetic alterations in proximal TCR signaling and implications for cancer immunotherapy","volume":"12","author":"Kent","year":"2021","journal-title":"Front Immunol"},{"key":"2026090219265034300_oyag319-B36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/imr.12772","article-title":"T cell receptor-based cancer immunotherapy: emerging efficacy and pathways of resistance","volume":"290","author":"Chandran","year":"2019","journal-title":"Immunol Rev"},{"key":"2026090219265034300_oyag319-B37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat Med"},{"key":"2026090219265034300_oyag319-B38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41392-020-00313-5","article-title":"Emerging role of tumor cell plasticity in modifying therapeutic response","volume":"5","author":"Qin","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2026090219265034300_oyag319-B39","doi-asserted-by":"crossref","first-page":"e1006225","DOI":"10.1371\/journal.pgen.1006225","article-title":"Intra-patient inter-metastatic genetic heterogeneity in colorectal cancer as a key determinant of survival after curative liver resection","volume":"12","author":"Sveen","year":"2016","journal-title":"PLoS Genet"},{"key":"2026090219265034300_oyag319-B40","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/cncr.28150","article-title":"High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma","volume":"119","author":"Mroz","year":"2013","journal-title":"Cancer"},{"key":"2026090219265034300_oyag319-B41","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ccell.2023.03.018","article-title":"Genomic mapping of metastatic organotropism in lung adenocarcinoma","volume":"41","author":"Lengel","year":"2023","journal-title":"Cancer Cell"},{"key":"2026090219265034300_oyag319-B42","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41467-023-36769-6","article-title":"Genomic and immune landscape of metastatic pheochromocytoma and paraganglioma","volume":"14","author":"Calsina","year":"2023","journal-title":"Nat Commun"},{"key":"2026090219265034300_oyag319-B43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-024-01767-7","article-title":"The two sides of chromosomal instability: drivers and brakes in cancer","volume":"9","author":"Hosea","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2026090219265034300_oyag319-B44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s42003-025-07606-x","article-title":"Genomic hallmarks of endocrine therapy resistance in ER\/PR+HER2- breast tumours","volume":"8","author":"Ghosh","year":"2025","journal-title":"Commun Biol"},{"key":"2026090219265034300_oyag319-B45","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.juro.2006.10.060","article-title":"Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival","volume":"177","author":"Lont","year":"2007","journal-title":"J Urol"},{"key":"2026090219265034300_oyag319-B46","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1002\/cam4.3232","article-title":"Nomogram prediction of overall survival based on log odds of positive lymph nodes for patients with penile squamous cell carcinoma","volume":"9","author":"Zheng","year":"2020","journal-title":"Cancer Med"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyag319\/70819014\/oyag319.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/9\/oyag319\/70819014\/oyag319.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/9\/oyag319\/70819014\/oyag319.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:27:09Z","timestamp":1788391629000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyag319\/8771792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,8,6]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyag319","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,6]]},"article-number":"oyag319"}}